These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 17942766)

  • 21. Mortality risk among hemodialysis patients receiving different vitamin D analogs.
    Tentori F; Hunt WC; Stidley CA; Rohrscheib MR; Bedrick EJ; Meyer KB; Johnson HK; Zager PG;
    Kidney Int; 2006 Nov; 70(10):1858-65. PubMed ID: 17021609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4.
    Abboud H; Coyne D; Smolenski O; Anger M; Lunde N; Qiu P; Hippensteel R; Pradhan RS; Palaparthy RV; Kavanaugh A; Melnick JZ; Williams LA; Batlle D
    Am J Nephrol; 2006; 26(1):105-14. PubMed ID: 16543714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D receptor activator reduces oxidative stress in hemodialysis patients with secondary hyperparathyroidism.
    Tanaka M; Tokunaga K; Komaba H; Itoh K; Matsushita K; Watanabe H; Kadowaki D; Maruyama T; Otagiri M; Fukagawa M
    Ther Apher Dial; 2011 Apr; 15(2):161-8. PubMed ID: 21426509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paricalcitol treatment of secondary hyperparathyroidism in hemodialysis patients on sevelamer hydrochloride: which dialysate calcium concentration to use?
    Sonikian M; Metaxaki P; Karatzas I; Vlassopoulos D
    Blood Purif; 2009; 27(2):182-6. PubMed ID: 19141997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of paricalcitol therapy for chronic kidney disease: a meta-analysis.
    Cheng J; Zhang W; Zhang X; Li X; Chen J
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):391-400. PubMed ID: 22223607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD.
    Kooienga L; Fried L; Scragg R; Kendrick J; Smits G; Chonchol M
    Am J Kidney Dis; 2009 Mar; 53(3):408-16. PubMed ID: 19185400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of oral paricalcitol on hyperparathyroidism and proteinuria in peritoneal dialysis patients.
    Coronel F; Rodríguez-Cubillo B; Cigarrán S; Gomis A
    Adv Perit Dial; 2011; 27():130-3. PubMed ID: 22073844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients.
    Lomonte C; Martino R; Selvaggiolo M; Bona RM; Cazzato F; Milano R; Chiarulli G; Basile C
    J Nephrol; 2003; 16(5):716-20. PubMed ID: 14733419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful Conversion From Parenteral Paricalcitol to Pulse Oral Calcitriol for the Management of Secondary Hyperparathyroidism in Hemodialysis Patients.
    Kumar J; Tran NT; Schomberg J; Streja E; Kalantar-Zadeh K; Pahl M
    J Ren Nutr; 2016 Jul; 26(4):265-9. PubMed ID: 27038806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D treatment in chronic kidney disease.
    Andress DL
    Semin Dial; 2005; 18(4):315-21. PubMed ID: 16076355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD.
    Coyne D; Acharya M; Qiu P; Abboud H; Batlle D; Rosansky S; Fadem S; Levine B; Williams L; Andress DL; Sprague SM
    Am J Kidney Dis; 2006 Feb; 47(2):263-76. PubMed ID: 16431255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe hyperparathyroidism despite paricalcitol therapy: one-year follow-up.
    Shuja SB; Raja RM
    Adv Perit Dial; 2003; 19():231-5. PubMed ID: 14763069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole or fragmentary information on parathyroid hormone?
    Drüeke TB; Fukagawa M
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1106-7. PubMed ID: 17928465
    [No Abstract]   [Full Text] [Related]  

  • 34. Converting to doxercalciferol capsules from intravenous paricalcitol or doxercalciferol.
    Kant KS; Gonzalez AR; Hariachar S; Bernardo M; Duggal A; Engstrand S; Hunter J; Plone M; Hertel J
    J Ren Nutr; 2012 Jan; 22(1):34-40.e2. PubMed ID: 21652220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
    Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
    Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism.
    Sprague SM; Llach F; Amdahl M; Taccetta C; Batlle D
    Kidney Int; 2003 Apr; 63(4):1483-90. PubMed ID: 12631365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of treatment with oral paricalcitol in patients with pre-dialysis chronic kidney disease.
    Hervás Sánchez JG; Prados Garrido MD; Polo Moyano A; Cerezo Morales S
    Nefrologia; 2011; 31(6):697-706. PubMed ID: 22130286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of paricalcitol with maxacalcitol injection in Japanese hemodialysis patients with secondary hyperparathyroidism.
    Akizawa T; Akiba T; Hirakata H; Kinugasa E; Tominaga Y; Fukagawa M; Yokoyama K; Zhang W; Linde PG; Suzuki M
    Ther Apher Dial; 2015 Jun; 19(3):225-34. PubMed ID: 25363733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats.
    Noonan W; Koch K; Nakane M; Ma J; Dixon D; Bolin A; Reinhart G
    Nephrol Dial Transplant; 2008 Dec; 23(12):3824-30. PubMed ID: 18644798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxercalciferol treatment of secondary hyperparathyroidism.
    Dennis VC; Albertson GL
    Ann Pharmacother; 2006 Nov; 40(11):1955-65. PubMed ID: 17062838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.